RxDoctor Payments Data

Steven Cannady, MD

Otolaryngology · Philadelphia, PANPI 1033394242

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,405 of the $33,116 with a category attached, or 88.8%. 10 manufacturers reported payments, led by Janssen Research & Development, LLC at 32.5% of the total. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,116in general payments, 2019–2025

Across 38 payments — averaging $871.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$11K
  • Medical Device Business Services, Inc.$10K
  • Zimmer Biomet$10K
  • Janssen Scientific Affairs, LLC$2K
  • Baxter Healthcare$136
  • Axogen$89
  • plus $202 from 4 others
$18,624in research payments, 2019–2025

Across 4 payments — averaging $4656.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sonavex, Inc.$19K

What the payments were for

  • Consulting fees$29,40589%
  • Travel & lodging$2,7288%
  • Food & beverage$9833%

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,116 in reported general payments places this provider in the 95th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$148,708
Medicare patients
189
Services billed
483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin11$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →